News
Is your dog's scratching keeping you up at night?! Here are 20 all-natural, inexpensive remedies available to you, for your ...
Women’s healthcare company Wisp has launched a diagnostics arm to offer low-cost testing at home for sexual and reproductive ...
The treatment for a cut on the penis usually depends on the underlying cause. For example, a doctor may prescribe an antibiotic or antiviral medication to treat an STI. For a yeast infection ...
5d
The Healthy @Reader's Digest on MSN4 Types of Toenail Fungus and How To Treat ThemIt can take up to a year for toenail fungus to completely resolve with treatment, and it can come back without proper ...
3d
Pets Radar on MSNDog struggling with seasonal allergies? Try these 4 simple, vet-approved solutionsAs we mentioned previously, washing your dog's paws and belly can be a total game-changer for seasonal allergies. However, if ...
See a healthcare provider for diagnosis and proper treatment for any kind of yeast infection in babies ... skin Children may have difficulty explaining their symptoms, so it’s best to assess the look ...
CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA ...
4d
EatingWell on MSNWhat Happens to Your Body When You Drink Apple-Cider Vinegar Every DayApple-cider vinegar is a trendy addition to a healthy diet, with some claims suggesting that ingesting it every day can ...
2d
The Mirror US on MSNDeadly fungus spreading as 'threat to humanity' that kills 60 percent of patientsThe UK Health Security Agency (UKHSA) said the fungus is "particularly concerning" because of its "remarkable resilience" ...
5d
Interesting Engineering on MSNYeast cells brew human DNase1 for first time, paving way for cheaper treatmentScientists produce human DNase1 in yeast for the first time, opening doors to wider clinical use and easier manufacturing.
5d
Pharmaceutical Technology on MSNScynexis resumes dosing in Phase III MARIO study after lengthy delayScynexis has resumed dosing of its Brexafemme (ibrexafungerp) drug in a Phase III trial after a 19-month clinical hold by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results